OSRH earnings: next report 2026-09-02, real EPS beat/miss history, P/E -0.13. Updated 2026-07-23.
OSR Holdings (OSRH) Research Hub
OSR Holdings (OSRH) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-08-26, shares last closed at 0.168 USD (+43.59%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.13, market cap 0.01B. This hub links to the full technical, earnings and options research available for OSRH.
Last updated 2026-08-26 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.168 USD (+43.59%) |
| 52-week range | 0.075 USD – 0.8 USD |
| Trend regime | Range |
| 14-day RSI | 38.9 (Bearish) |
| Trailing P/E | -0.13 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for OSRH
Covered Call on OSRH: how it works, illustrative setup around the real 0.168 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OSRH: how it works, illustrative setup around the real 0.168 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OSRH: how it works, illustrative setup around the real 0.168 USD price, max profit/loss, breakeven and when to use it. Educational.
OSRH technical analysis: range, last 0.168 USD, RSI 38.9, 52w range 0.075 USD–0.8 USD, real support/resistance. Updated 2026-08-26.
Frequently asked questions
What sector is OSRH in?
OSR Holdings (OSRH) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is OSRH in an uptrend or downtrend?
As of 2026-08-26, OSRH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OSRH's trailing P/E ratio?
OSRH's trailing P/E is -0.13, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does OSRH next report earnings?
OSRH is next scheduled to report earnings on 2026-09-02, with a consensus EPS estimate of -0.28 USD.